Meeting Requirements for Certification as a Leading Company in Dementia Overcoming

Samjin Pharmaceutical announced on the 24th that the company conducted a “Dementia Partner” training for employees, organized by the Mapo-gu Dementia Safety Center, at the company’s auditorium in Mapo-gu, Seoul, on the 21st.


The status of “Leading Company in Dementia Overcoming” is granted to companies that contribute to creating a dementia-friendly environment as part of the national dementia management program promoted by the Central Dementia Center under the Ministry of Health and Welfare. This is based on employees’ completion of dementia partner training and utilization of corporate infrastructure.


Samjin Pharmaceutical held 'Dementia Partner' training for its employees on the 21st at its headquarters auditorium in Mapo-gu, Seoul, organized by the Mapo-gu Dementia Safety Center. Samjin Pharmaceutical

Samjin Pharmaceutical held 'Dementia Partner' training for its employees on the 21st at its headquarters auditorium in Mapo-gu, Seoul, organized by the Mapo-gu Dementia Safety Center. Samjin Pharmaceutical

View original image

Samjin Pharmaceutical employees broadened their understanding and empathy for building a dementia-friendly environment through this training, which covered topics such as the definition, causes, and prevention of dementia, as well as effective communication methods with dementia patients.


By completing the Dementia Partner training and meeting the requirements for certification as a leading company in dementia overcoming, Samjin Pharmaceutical plans to participate in building a community dementia safety network in collaboration with dementia safety centers.



Samjin Pharmaceutical CEO Kim Sangjin stated, “With this certification effort as a starting point, we will continue our social contribution activities to fulfill our social responsibilities and values as a pharmaceutical company.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing